Sarah is a Project Director for a variety of research projects at ANSIRH that aim to expand access to reproductive health care in the U.S. and internationally. Her work focuses on measuring morbidity and mortality due to unintended pregnancy and unsafe abortion, evaluating the impact of abortion restrictions on women’s health and wellbeing, and designing and implementing new models for family planning and abortion service provision. Previously, Ms. Raifman managed the Global Turnaway Study at ANSIRH, completed a UCSF fellowship on international family planning advocacy, and conducted evaluations of the LifeWrap, a first aid device to prevent mortality and morbidity from postpartum hemorrhage. She began her work in reproductive health at the Population Council, where she evaluated community-based reproductive health programs in Africa and Asia. She brings significant experience in quantitative and qualitative research and program management, and is dedicated to improving the health and wellbeing of vulnerable populations. She received her BA in Development Studies from Brown University and her MSc in Global Health from the Harvard School of Public Health.
December 18, 2020
Ralph LJ Foster DG Biggs MA Samari G Upadhyay UD Gerdts C Grossman D. Prevalence of self-managed abortion among women of reproductive age in the United States. December 2020. JAMA, 3(12):e2029245.
May 12, 2020
Landau C Sella S Grossman D. Mifepristone–misoprostol versus misoprostol-alone regimen for medication abortion at 24 weeks’ gestation. May 2020. Contraception, 102(2):99-103.
January 1, 2020
Daniel S Kaller S Grossman D. Characteristics of patients having telemedicine versus in-person informed consent visits before abortion in Utah. January 2020. Contraception, 101(1):56-61.
October 15, 2019
Grossman D Bessenaar T Duong LD Tamang A Dragoman MV. Experiences with pain of early medical abortion: qualitative results from Nepal, South Africa, and Vietnam. October 2019. BMC Women's Health, 19:118.